-
Dec 7, 2023
Tandem Diabetes Care, Inc. has announced the release of updated t:slim X2™ insulin pump software featuring integration with Dexcom G7 Continuous Glucose Monitoring (CGM) technology in the United States. The company plans to provide a complimentary remote software update to all in-warranty t:slim X2 users, allowing them to access Dexcom's latest CGM advancements. New t:slim X2 pumps with the integrated software are currently being shipped to customers, while the Dexcom G7 integration is expected to launch in additional countries outside the U.S. in early 2024.
-
Nov 16, 2023
AI is a tool to amplify human expertise, not replace it. Its footprint in diabetes technology is already substantial and growing rapidly. Like everyone, healthcare professionals need to stay informed and even, embrace AI's role in diabetes care for better patient outcomes.
-
Nov 16, 2023
Insulet Corporation has received FDA clearance for its Omnipod 5 App for iPhone, becoming the first company to offer a tubeless automated insulin delivery system with complete control via compatible Android and iOS smartphones. It will integrate with the Dexcom G6 Continuous Glucose Monitoring System initially, with a full market release in 2024, and is available at no cost to Omnipod 5 System users.
-
Nov 16, 2023
Dexcom is in the process of discontinuing Dexcom G6. They are working in phases to transition all of their customers to Dexcom G7 and stand-alone Dexcom G6 systems are the first phase.
-
Nov 16, 2023
The tubeless Accu-Chek Solo micropump system from Roche has gained FDA approval, providing a new insulin delivery solution for individuals aged 2 years and older with type 1 diabetes.